NOMD vs. CPRX
NOMD (Nomad Foods Limited) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. NOMD operates in Packaged Foods (Consumer Defensive), while CPRX operates in Biotechnology (Healthcare). Over the past 10 years, NOMD returned 2.48%/yr vs 46.26%/yr for CPRX. At a 0.16 correlation, their price movements are largely independent.
Performance
NOMD vs. CPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NOMD achieves a -13.98% return, which is significantly lower than CPRX's 34.36% return. Over the past 10 years, NOMD has underperformed CPRX with an annualized return of 2.48%, while CPRX has yielded a comparatively higher 46.26% annualized return.
NOMD
- 1D
- 0.58%
- 1M
- 14.74%
- YTD
- -13.98%
- 6M
- -12.86%
- 1Y
- -37.18%
- 3Y*
- -13.18%
- 5Y*
- -17.90%
- 10Y*
- 2.48%
CPRX
- 1D
- -0.03%
- 1M
- 0.64%
- YTD
- 34.36%
- 6M
- 32.77%
- 1Y
- 29.11%
- 3Y*
- 39.03%
- 5Y*
- 40.44%
- 10Y*
- 46.26%
NOMD vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NOMD Nomad Foods Limited | -13.98% | -22.15% | 2.39% | -1.68% | -32.10% | -0.12% | 13.63% | 33.79% | -1.12% | 76.70% |
CPRX Catalyst Pharmaceuticals, Inc. | 34.36% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
Correlation
The correlation between NOMD and CPRX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jan 4, 2016 | 0.16 |
The correlation between NOMD and CPRX shifts across timeframes, from 0.07 (1 year) to 0.18 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
NOMD:
$1.48B
CPRX:
$3.98B
NOMD:
€0.91
CPRX:
$1.74
NOMD:
9.92
CPRX:
18.02
NOMD:
16.02
CPRX:
0.32
NOMD:
0.44
CPRX:
6.68
NOMD:
0.51
CPRX:
3.93
NOMD:
€3.00B
CPRX:
$596.96M
NOMD:
€798.02M
CPRX:
$378.23M
NOMD:
€343.69M
CPRX:
$313.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOMD vs. CPRX — Risk / Return Rank
NOMD
CPRX
NOMD vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nomad Foods Limited (NOMD) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NOMD | CPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.08 | ||
| Sortino ratioReturn per unit of downside risk | -3.15 | ||
| Omega ratioGain probability vs. loss probability | 0.78 | 1.18 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.79 | 1.52 | -2.32 |
| Martin ratioReturn relative to average drawdown | -1.18 | 3.46 | -4.63 |
Loading charts...
Drawdowns
NOMD vs. CPRX - Drawdown Comparison
The maximum NOMD drawdown since its inception was -67.99%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for NOMD and CPRX.
Loading charts...
Drawdown Indicators
| NOMD | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.99% | -94.25% | +26.26% |
Max Drawdown (1Y)Largest decline over 1 year | -47.12% | -19.18% | -27.94% |
Max Drawdown (3Y)Largest decline over 3 years | -52.77% | -27.29% | -25.48% |
Max Drawdown (5Y)Largest decline over 5 years | -67.17% | -45.37% | -21.80% |
Max Drawdown (10Y)Largest decline over 10 years | -67.99% | -64.87% | -3.12% |
Current DrawdownCurrent decline from peak | -63.27% | -0.03% | -63.24% |
Average DrawdownAverage peak-to-trough decline | -25.33% | -51.96% | +26.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.68% | 9.84% | +21.84% |
Volatility
NOMD vs. CPRX - Volatility Comparison
Nomad Foods Limited (NOMD) has a higher volatility of 10.46% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 0.47%. This indicates that NOMD's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOMD | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.46% | 0.47% | +9.99% |
Volatility (6M)Calculated over the trailing 6-month period | 24.57% | 23.17% | +1.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.36% | 33.28% | -1.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.27% | 47.77% | -18.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.71% | 60.39% | -31.68% |
Dividends
NOMD vs. CPRX - Dividend Comparison
NOMD's dividend yield for the trailing twelve months is around 6.52%, while CPRX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% |
NOMD Nomad Foods Limited | 6.52% | 5.44% | 3.58% |
Financials
NOMD vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Nomad Foods Limited and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NOMD vs. CPRX - Profitability Comparison
NOMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nomad Foods Limited reported a gross profit of 186.62M and revenue of 726.96M. Therefore, the gross margin over that period was 25.7%.
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.
NOMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nomad Foods Limited reported an operating income of 67.70M and revenue of 726.96M, resulting in an operating margin of 9.3%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.
NOMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nomad Foods Limited reported a net income of 29.38M and revenue of 726.96M, resulting in a net margin of 4.0%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.
Frequently Asked Questions
NOMD and CPRX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NOMD has higher volatility (10.46%) compared to CPRX (0.47%). In terms of maximum drawdown, NOMD dropped -67.99% vs CPRX's -94.25%.
CPRX currently has the higher Sharpe Ratio (0.89 vs -1.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NOMD and CPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer